NAD+ vs MOTS-c
NAD+ and MOTS-c both occupy central positions in mitochondrial and longevity research, but they represent different levels of intervention. NAD+ is a fundamental coenzyme whose declining intracellular levels are closely associated with aging, acting through sirtuin activation, PARP-mediated DNA repair, and the NAD+/NADH redox cycle. MOTS-c is a recently identified mitochondrial-derived peptide that signals from the mitochondria to the nucleus, activating AMPK and metabolic pathways associated with insulin sensitivity and metabolic homeostasis. Researchers studying cellular aging from an energy metabolism or mitochondrial biology angle frequently evaluate both compounds.
NAD+
Dinucleotide coenzyme (oxidized form)
MOTS-c
Mitochondrial-derived peptide (16 amino acids)
At a Glance
Key research profiles for each compound.
NAD+
Coenzyme studied for DNA repair, sirtuin activation, and cellular energy metabolism
Class
Dinucleotide coenzyme (oxidized form)
Mechanism
Sirtuin activation, PARP substrate, NAD+/NADH redox cycling
Half-Life
Short intracellular turnover, supplements replenish precursor pools
Research Area
DNA repair, mitochondrial biology, cellular aging
- Investigated for sirtuin (SIRT1 to SIRT7) activation and epigenetic regulation
- Studied for PARP-dependent DNA repair mechanisms in aging cell models
- Documented role in mitochondrial biogenesis via PGC-1alpha pathway signaling
- Examined for cellular energy metabolism and NAD+/NADH redox balance research
MOTS-c
Mitochondrial-derived peptide studied for AMPK activation and metabolic regulation
Class
Mitochondrial-derived peptide (16 amino acids)
Mechanism
AMPK activation, AICAR pathway, retrograde mitochondrial signaling
Half-Life
Estimated short clearance in preclinical models
Research Area
Metabolic regulation, insulin sensitivity, longevity
- Studied for AMPK activation and AICAR-dependent metabolic signaling
- Investigated for skeletal muscle insulin sensitivity and glucose uptake in models
- Examined for effects on obesity and metabolic syndrome markers in animal studies
- Documented role in mitochondria-to-nucleus retrograde signaling
Side-by-Side Comparison
Key research parameters compared directly.
| Feature | NAD+ | MOTS-c |
|---|---|---|
| Compound Class | Dinucleotide coenzyme | Mitochondrial-derived peptide (16 AA) |
| Primary Mechanism | Sirtuin activation, PARP substrate, redox cycling | AMPK activation, AICAR pathway, retrograde signaling |
| Research Focus | DNA repair, mitochondrial biogenesis, aging | Metabolic regulation, insulin sensitivity, longevity |
| Origin | Universal cellular coenzyme, supplemented as precursor | Encoded in mitochondrial 12S rRNA gene |
| Pathway Level | Upstream coenzyme substrate for many enzymes | Peptide hormone with downstream AMPK activation |
| Tissue Focus | Broadly relevant across all cell types | Skeletal muscle, liver, adipose tissue primary focus |
| Research Timeline | Decades of foundational biochemistry research | Identified in 2015 (Lee et al., Cell Metabolism) |
| Longevity Relevance | NAD+ decline linked to aging across species | MOTS-c levels decline with age in animal models |
Research Deep-Dive
NAD+
NAD+ (nicotinamide adenine dinucleotide) is one of the most fundamental coenzymes in cellular biology, participating in hundreds of metabolic reactions as an electron carrier. In aging research, its significance centers on three interconnected mechanisms. First, NAD+ is the essential substrate for sirtuin deacylases (SIRT1 through SIRT7), which regulate epigenetic gene expression, mitochondrial function, and stress response pathways. Second, NAD+ is the substrate for PARP enzymes (poly-ADP ribose polymerases), which are central to DNA strand break repair. Third, the NAD+/NADH ratio serves as a key regulator of cellular redox state and metabolic flux. Intracellular NAD+ levels decline with age across multiple species, making its replenishment a major focus of longevity research.
View NAD+ →MOTS-c
MOTS-c (Mitochondrial-derived Open reading frame within 12S rRNA, type c) is a 16-amino acid peptide encoded within the mitochondrial 12S rRNA gene, identified in 2015 by Lee et al. in Cell Metabolism. Unlike most peptide hormones encoded in nuclear DNA, MOTS-c is translated in the mitochondria and then translocated to the nucleus under metabolic stress conditions, where it regulates gene expression through AMPK-dependent pathways. In animal studies, MOTS-c administration has been associated with improved insulin sensitivity, reduced adiposity, and enhanced exercise performance. MOTS-c plasma levels decline with age and are lower in subjects with obesity and metabolic dysfunction, positioning it as a molecule of interest in metabolic aging research.
View MOTS-c →Research Context
NAD+ and MOTS-c operate on the same mitochondrial biology axis but at different levels. NAD+ functions as the upstream coenzyme substrate that enables mitochondrial energy production and sirtuin-based epigenetic regulation. MOTS-c is a downstream signaling peptide that communicates mitochondrial metabolic status to the rest of the cell. Researchers building comprehensive mitochondrial aging models frequently include both to capture the coenzyme-level and peptide-signaling dimensions of mitochondrial biology.
Frequently Asked Questions
Related Comparisons
Research Stacks
Source Both Compounds
NAD+ and MOTS-c are both available from Spartan Peptides at ≥98% HPLC-verified purity. Domestic US supply, same-day dispatch before 2 PM. All products for in-vitro research use only.
All compounds are strictly for in-vitro research use only and not intended for human consumption.